PMID: 9174188Jun 1, 1997Paper

Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods

Antimicrobial Agents and Chemotherapy
J C ChangK T Luh

Abstract

A total of 106 clinical isolates of flavobacteria, including 41 isolates of Flavobacterium meningosepticum, 59 of Flavobacterium indologenes, and 6 of Flavobacterium odoratum were collected from January 1992 to December 1995 from patients in Taiwan. The in vitro activities of antimicrobial agents were determined concomitantly by the standard agar dilution and disk diffusion methods. More than 90% of the flavobacterial isolates were resistant to cephalothin, cefotaxime, ceftriaxone, moxalactam, aztreonam, imipenem, aminoglycosides, erythromycin, and glycopeptides. The majority of F. meningosepticum isolates were susceptible to piperacillin and to minocycline but resistant to ceftazidime, with MICs at which 90% of the isolates are inhibited being 8, 4, and > 128 microg/ml, respectively. Approximately half of the F. indologenes isolates were susceptible to piperacillin, cefoperazone, ceftazidime, and minocycline, with MICs at which 50% of the isolates are inhibited being 4, 16, 8, and 4 microg/ml, respectively. The majority of F. odoratum isolates were resistant to all the antimicrobial agents tested except minocycline, to which five of six isolates were susceptible. With least-squares regression analysis and error rate-bounded an...Continue Reading

References

Sep 1, 1978·Antimicrobial Agents and Chemotherapy·R C AberR C Moellering
Mar 1, 1976·Archives of Disease in Childhood·E L LeeS D Puthucheary
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·P A Bradford, C C Sanders
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·J H JorgensenA W Howell
Jan 25, 1991·American Journal of Ophthalmology·F A Bucci, E J Holland
Apr 1, 1985·The Journal of Antimicrobial Chemotherapy·M O HussonH Leclerc
Nov 1, 1988·The American Journal of Medicine·T UchiharaH Tsukagoshi
Jan 1, 1987·Medical Microbiology and Immunology·Y Siegman-IgraN Konforti
Nov 1, 1986·The Journal of Antimicrobial Chemotherapy·B E Scully, H C Neu
May 1, 1971·Journal of Medical Microbiology·G Altmann, B Bogokovsky
Dec 1, 1974·The Journal of Infectious Diseases·C M Metzler, R M DeHaan
Mar 1, 1972·American Journal of Clinical Pathology·S Werthamer, M Weiner
Jul 1, 1981·Antimicrobial Agents and Chemotherapy·E YabuuchiA Ohyama
Aug 1, 1983·Antimicrobial Agents and Chemotherapy·D A StrandbergD J Drutz
Apr 1, 1981·Journal of Clinical Pathology·M L ThongE L Lee
Nov 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P R HsuehW C Hsieh
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·P R HsuehJ J Wu
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P R HsuehW C Hsieh
Sep 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P R HsuehK T Luh
Mar 1, 1961·American Journal of Diseases of Children·R M GEORGEW E WHEELER

❮ Previous
Next ❯

Citations

Jan 16, 2004·Scandinavian Journal of Infectious Diseases·Jen-Tsun LinPo-Min Chen
Jul 7, 2015·Transplantation Direct·Hong LiuDavid K C Cooper
Mar 1, 2002·Scandinavian Journal of Infectious Diseases·B T GreenP E Nolan
Mar 19, 2002·Emerging Infectious Diseases·Po-Ren HsuehKwen-Tay Luh
Aug 17, 2004·Scandinavian Journal of Infectious Diseases·Akiko AdachiShinichiro Okamoto
Dec 17, 2015·Internal Medicine·Hideharu HagiyaFumio Otsuka
Dec 18, 2013·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·M S Ratnamani, Ratna Rao
Apr 14, 2015·Indian Journal of Medical Microbiology·S GargN Taneja

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.